利用病毒感染/疫苗接种将高亲和性T细胞群集中到瘤中,使用瘤性病毒免疫疗法
Alexa Veliz Rios1, Muriel Metko1, Jason Tonne1
1Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
概括
通过重定向先前存在的抗病毒T细胞反应,可以增强癌症免疫疗法. 这项研究表明使用SARS-CoV-2抗原与瘤病毒或CAR-T细胞将T细胞集中在瘤上,从而导致瘤治愈.
科学领域:
- 免疫学
- 癌症学
- 病毒学
背景情况:
- 免疫耐受性限制了T细胞对自身瘤相关抗原 (TAA) 的反应,阻碍了癌症免疫治疗.
- 病毒感染主要是高亲和性T细胞, 提供一种克服这种局限性的潜在策略.
研究的目的:
- 研究使用已存在的抗病毒T细胞记忆对抗SARS-CoV-2抗原以增强抗瘤免疫力.
- 探索瘤解毒病毒 (OV) 和虚拟抗原受体 (CAR) -T细胞传递病毒抗原以向瘤.
主要方法:
- 使用SARS-CoV-2抗原 (Mem或Spike蛋白) 的异质原始和OV/提升策略.
- 提供SARS-CoV-2抗原表达载体的化学抗原受体 (CAR) - T细胞疗法.
- 在体内用S蛋白疫苗增强S特异性CAR- T细胞.
主要成果:
- 使用T细胞聚焦的SARS-CoV-2抗原实现了CD8+T细胞依赖性瘤治愈,证据表明表位扩散对抗TAA.
- 即使在免疫前的小鼠中,CAR-T细胞也成功将SARS-CoV-2抗原载体输送到瘤中.
- 在体内增强CAR- T细胞增强了抗瘤活性和持久性.
结论:
- 通过OV或CAR-T细胞传递病毒抗原来利用先前存在的抗病毒T细胞反应是产生高亲和性T细胞用于癌症免疫治疗的可行策略.
- 这种方法提供了当高亲和力抗瘤T细胞不易获得时的治疗替代方案.
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Immune Response Against Viral Pathogens
917
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
917
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


